35 related articles for article (PubMed ID: 38555652)
1. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
2. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract][Full Text] [Related]
3. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
4. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract][Full Text] [Related]
5. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
6. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
7. Myxopapillary Ependymoma with Anaplastic Features: A Case Series and Review of the Literature.
Khristov V; Shenoy G; Mau C; Mrowczynski O; Rizk E; Pu C; Specht CS; Aregawi D
World Neurosurg; 2022 Feb; 158():e735-e745. PubMed ID: 34800728
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review.
Abdallah A; Emel E; Gündüz HB; Sofuoğlu ÖE; Asiltürk M; Abdallah BG
World Neurosurg; 2020 Apr; 136():e245-e261. PubMed ID: 31899399
[TBL] [Abstract][Full Text] [Related]
9. Disseminated spinal myxopapillary ependymoma in an adult at initial presentation: a case report and review of the literature.
Straus D; Tan LA; Takagi I; O'Toole JE
Br J Neurosurg; 2014 Oct; 28(5):691-3. PubMed ID: 24460084
[TBL] [Abstract][Full Text] [Related]
10. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
Gitto L; Serinelli S; Galbraith K; Williams M; Mirchia K; Galgano MA; Krishnamurthy S; de la Roza G; Viapiano MS; Walker JM; Jour G; Serrano J; DeLorenzo M; Snuderl M; Richardson TE
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1044-1053. PubMed ID: 32743660
[TBL] [Abstract][Full Text] [Related]
12. Ependymoma.
Reni M; Gatta G; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2007 Jul; 63(1):81-9. PubMed ID: 17482475
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
